Skip Navigation



Rheumatology Advance Access published online on November 23, 2004
Rheumatology, doi:10.1093/rheumatology/keh483
Rheumatology © British Society for Rheumatology 2004; all rights reserved
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow CME/CE:
Take the course for this article:
 Rheumatology First Quarter 2005 Quiz
Right arrow All Versions of this Article:
44/3/271    most recent
keh483v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mpofu, S.
Right arrow Articles by Moots, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mpofu, S.
Right arrow Articles by Moots, R. J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Received April 6, 2004
Accepted October 15, 2004

Review

Anti-TNF-{alpha} therapies: they are all the same (aren't they?)

S. Mpofu 1, F. Fatima 1, and R. J. Moots 1*

1 Academic Rheumatology Unit, University of Liverpool, Clinical Sciences Centre, University Hospital Aintree, Longmoor Lane, Liverpool L9 7AL, UK

* To whom correspondence should be addressed.
R. J. Moots, E-mail: rjmoots{at}liv.ac.uk



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
V. Strand, A. Balbir-Gurman, K. Pavelka, P. Emery, N. Li, M. Yin, P. B. Lehane, and S. Agarwal
Sustained benefit in rheumatoid arthritis following one course of rituximab: improvements in physical function over 2 years
Rheumatology, December 1, 2006; 45(12): 1505 - 1513.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. Dziadzio, V. Reddy, S. Rahman, C. Mummery, and A. Keat
Is TNF{alpha} really a good therapeutic target in motoneuronal degeneration? A case of amyotrophic lateral sclerosis in a patient with RA receiving infliximab
Rheumatology, November 1, 2006; 45(11): 1445 - 1446.
[Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
C. Sheehy, E. Murphy, and M. Barry
Effective co-administration of infliximab and etanercept following the failure of sequential anti-TNF agents in a patient with HLA-B27-associated arthropathy
Rheumatology, October 1, 2006; 45(10): 1314 - 1315.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.